CARYX | MOJCX | CARYX / MOJCX | |
Total Expense Ratio | 0.77 | 3.00 | 26% |
Annual Report Gross Expense Ratio | 0.77 | 3.80 | 20% |
Fund Existence | 11 years | 8 years | - |
Gain YTD | 1.672 | 3.723 | 45% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.35B | 70.8M | 3,319% |
Annual Yield % from dividends | 2.54 | 0.00 | - |
Returns for 1 year | 6.27 | 4.92 | 128% |
Returns for 3 years | 11.30 | 32.14 | 35% |
Returns for 5 years | 9.56 | 85.46 | 11% |
Returns for 10 years | 19.84 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OSCIX | 40.90 | 0.10 | +0.25% |
Invesco International Small-Mid Com R6 | |||
ETNMX | 14.25 | -0.01 | -0.07% |
Eventide Balanced Fund Class N | |||
TQGIX | 18.75 | -0.06 | -0.32% |
T. Rowe Price Integrated Global Eq I | |||
JLGPX | 76.46 | -0.49 | -0.64% |
JPMorgan Large Cap Growth R3 | |||
BIVIX | 16.89 | -0.20 | -1.17% |
Invenomic Institutional |